R

Redhill Biopharma Ltd
D

RDHL

2.00000
USD
-0.04
(-1.96%)
مغلق
حجم التداول
169
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,583,108
أصول ذات صلة
A
AKRO
-0.125
(-0.24%)
51.760 USD
A
ALLO
-0.00500
(-0.42%)
1.18500 USD
D
DRRX
0.04160
(6.24%)
0.70830 USD
G
GNFT
0.10000
(2.62%)
3.92000 USD
I
IMUX
0.02270
(3.20%)
0.73250 USD
K
KALA
-0.02000
(-0.39%)
5.16000 USD
R
RCKT
0.04000
(1.39%)
2.92000 USD
S
SNGX
-0.06000
(-4.80%)
1.19000 USD
المزيد
الأخبار المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-relatedproducts in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.